Business
HCi Viocare Targets the Global Diabetes Market by Shipping the 1st Smart Diabetic Walker Boot
HCi Viocare Targets the Global Diabetes Market by Shipping the 1st Smart Diabetic Walker Boot.
About this update from Rafina Innovations Inc.
[{"type":"text","content":"\n \n \n HCi Viocare Targets the Global Diabetes Market by Shipping the 1st Smart Diabetic Walker Boot\n \n \nHCi Viocare Targets the Global Diabetes Market by Shipping the 1st Smart Diabetic Walker Boot\n \n GLASGOW, SCOTLAND--(Marketwired - Aug 17, 2017) - HCi Viocare (OTCQB: VICA) is pleased to announce that it has shipped the world's 1st Smart Diabetic Walker Boot, equipped with the company's patent pending Flexisense technology, to a global diabetes-market leading manufacturer.\n The Flexisense smart diabetic walker allows the user or the clinician to identify high pressure or shear force areas without having to remove the boot. Removing the walker throughout the day to check for pressure sores could lead to prolonged healing time. The smart boot is especially useful for diabetic user who must ensure their feet are kept clean and in good condition. Any high forces or pressure points can be analysed and resolved immediately, rather than at the end of the day, which can be too late. If sores are prevented, then there would be a reduction in diabetic ulcers which can cause serious health problems, are expensive to treat and can lead to amputation.\n According to the WHO[1] there are 422 million people with diabetes world-wide, and 25% of them will develop diabetic foot condition at some point in their lives. In the USA alone the cost of treatment for foot ulcers has surpassed the 13 billion dollars mark and continues to rise[2]. The importance of a smart diabetic walker that can monitor ulcerations is therefore paramount.\n In addition, the Flexisense sensors can provide information about the wear of the diabetic walker, as well as compliance information, required by insurance companies, via wireless transition and IoT.\n Dr. Christos Kapatos, HCi Viocare's co-founder and CTO, stated: \"Diabetes is the epidemic of our times and the diabetic foot condition effects millions of people world-wide. We are very happy and proud to present our Flexisense smart diabetic walker which is designed to monitor the health of the diabetic foot and assist in preventing ulcerations. Millions of people suffer from the effects of foot ulcers that limit their mobility and affect their lives. The purpose of technology is to improve the lives of all people and this is what we are doing with Flexisense and with our smart diabetic walker. We expect ou...